Options
Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis - A Systematic Review of Population-Based Data
Journal
Risk management and healthcare policy
Journal Volume
16
End Page
2099
Date Issued
2023
Author(s)
Abstract
Early studies showed that the risks of mRNA vaccine-associated myocarditis and pericarditis are low but with substantial variation across studies. Study characteristics, ethnicity, vaccine types, dose intervals, and SARS-CoV-2 infection prevalence may influence the rates of myocarditis and pericarditis after mRNA vaccination in population-based studies.
Subjects
COVID-19; mRNA vaccine; myocarditis; population-based study; surveillance data
Type
journal article